{"name":"EpiEndo Pharmaceuticals","slug":"epiendo-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxPTWpXc3VzY3BHVkgtSzBYbE4zc2Rkenc4ZGNYUUZCenVDaEVXdGtYT1pEVWlsWjNmQnplMjNPQjdsaVRhOFdQUDN1eUdUTFQwZUxfOUIwa2NZdFJhZk5lQXZ0ZWpmQzkwY3lLb1dtSnQ2dGlWamJ2NTFhckFreFZNbmtyLXJ2T3lPeG0yMENQOFgxdEhobklMU2VHOVBLYUNyX01iVjRyOVdRZTM2WDB6MncwUk96aUM2TElVRmVDSWFpaTBIU1pXQWJWNUJCcXlsTHBwYmJXdUNDYVFPT09TeVBEaW1HZ0xqMG1MdlgxcF9YTVBRVEIyR3d3anRnTUptcGhsQktRazlzNk9HTmtTV2ZNMGNxOEw3QTR6QThFbDZUazBOekJlRlRmV3Z0b2h4ckdnYnlqMDFvU25rVVdRV1ZTaTFJVl9aZFdzOUEyM3M?oc=5","date":"2026-04-08","type":"pipeline","source":"Barchart.com","summary":"COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma, AstraZene","headline":"COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxOdmJtTy1PVXBHWGpWQ0dlM1otWU01LWJUZ0MtM0ZpRklNbW44d1BBdTR4WlRvdXViT1NTNW5VTlFKSXZoRTJSYkJadHVoTFh0R0lNQnV2VEtaUnptVmxYeWhkNU0tUldGRHdxSUh6YWd2ZWdWMzBrbVR6QVgwd0NlRV91MGY4aUdwR1lpMXJfcnJLQnp1eUF4UW5LaDBzcHdoZWxOdnlKeVE4M3ZpZ3k2czdmTjh3UUxnX2FXZ2dGNm5YTzJJVEtPUTNuZUxQLWRLWmtOTUpKMklFd29GU25xUVNWMTNGdkljeTJVdEJvdi1TTTBXWDFTWW0tRi1hNkFEbm56dUp5ZTV3Mm96bmFXZ1dFVWZ2Qk12UVpZR09B?oc=5","date":"2026-03-30","type":"trial","source":"Barchart.com","summary":"Chronic Obstructive Pulmonary Disease Clinical Trial Pipeline Appears Robust With 65+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com","headline":"Chronic Obstructive Pulmonary Disease Clinical Trial Pipeline Appears Robust With 65+ Key Pharma Companies Actively Work","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQckZOTGdZVVhfUVFfRGJKa2pENXg2Y21zNkM1bi1oeGVtS3d3QW9rY1RKeUpoT3NxQ1VEWHBVNDZWMXZ1SjBSWV8tTkZkWTVEZWlTTVJqNDh3ZEs4Rk9qcTNydmRCX2FvaWtsdkRGeFNCejk3bWpiQU15ME5JU3FVeEZpSjA4SFEtRE9fY2hGMmlLQTVlZGlTYzczQUtmZmRaaDV6bU10cDlZNkxhblZLU0xMMmxnS2g5dTFyR0UzdmhHTmxnOGdEeGZhbk5RQQ?oc=5","date":"2024-08-14","type":"pipeline","source":"EU-Startups","summary":"Reykjavik-based PLAIO raises €4.3 million to expand its AI planning platform for pharma industry - EU-Startups","headline":"Reykjavik-based PLAIO raises €4.3 million to expand its AI planning platform for pharma industry - EU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1RcU1aQTJaMWZKQ0gwcndXZkR5VVIxeWRoRmNJajlsN1hxX2loX3V0OWNUdXowZ0lsZWM2ZTJnT183enRlUEZVZmxHSnllSjVqSDVGcDlJa0hndTVubUFaUmdoSHNQR2Y1c1ZvU3pzbGpMTHBtY0gtel9jQWdDdw?oc=5","date":"2024-08-14","type":"pipeline","source":"Silicon Canals","summary":"Iceland’s AI pharma planning platform PLAIO raises €4.3M - Silicon Canals","headline":"Iceland’s AI pharma planning platform PLAIO raises €4.3M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPMlhQOUZ2Qmd4Y1NtUThCTGpJXzNwUXQtbzc3d3BmcGd5MnQ2LVFWMHQxVTRYZDlTQVJvTkRGcFVTWVBBTDN2MzhpVktZOGJDTUZRc2VrSW1BemxKeTJrOFFXUFZSbk1JZ1lpQnI1M29NdkhWZWhVc1JPWTgxQzFBQmJZbjZveHNSdFo2ZFF3ZlNOUXRpZnpmelUxeWNrTmEtUVpYeEJXTFlOREFxeXc4V3M3SHNjMEptUG1NbUF3TnY2NHhydE8tRWdlaXRPdFd1TURUNXc3c0ltRDZZY1hFdjNBN1hNQnZ5Y2EtLQ?oc=5","date":"2021-10-25","type":"pipeline","source":"Business Wire","summary":"EpiEndo Pharmaceuticals wins the Swedish American Life Sciences Summit (SALSS) Rising Star Award 2021 - Business Wire","headline":"EpiEndo Pharmaceuticals wins the Swedish American Life Sciences Summit (SALSS) Rising Star Award 2021","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxNdVlrdjgtNEpQMTNreWF5RTludXBmM29HTlI2c3B5RDI5N3FkaHZXMGkxVGd0a2tVNGUtZDBPS3FsMXpvQlgwQVFfUEticTA4Q1E1b19uUUVPVUkzajhQVHQ4b2xRNEdCQnF4XzdHU05lSkw0YlVleGNlRlhsaVlKMmwtOVdUNGdvTWFiUjFDUGw5YzkwOVAyZHVoVGRna19fRVVXV3VrRzQ1ZFdtWUp2Y1lsSFR0ZVVuV2ROY0dQS3pPU3dxYTRNaUtlMkQteTJzdmZMQWhOQ0FGVHZrWlpLMzJ0aUdpQXA3UUFrX0tIdTZ0UzlRSy00V2liRVRkQnpqMTdqRzE2VTUtVjhUOWl6UTR6LWVKY1hkWi1sbGVfQnhTb19BYUFrdm5qVmFKWXdrdFNoQQ?oc=5","date":"2021-08-18","type":"pipeline","source":"Business Wire","summary":"EpiEndo Pharmaceuticals Secures EUR 20 Million Series A Funding to Advance Clinical Development of its Non-Antibiotic Macrolide for the treatment of COPD - Business Wire","headline":"EpiEndo Pharmaceuticals Secures EUR 20 Million Series A Funding to Advance Clinical Development of its Non-Antibiotic Ma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxOaHF1OUI2UkNlVTNVWExGaURQcGg1VHVnMUdxTlkxMW9RTnNuM2VfR0dUcnJ2aDR5WE5aQlZkVjRnUDhab1NsRE5SNWJRWHpmSDVidU5wSEhEMk5SRnlkeU5GODl2NEtRUE1xOEJfM2s1dUZmVWdDNC1WS1A5VWR3dkh6SlZxbmZ3SS1nZ0tDUkQweXNfYTJiczhFejZPOXR6c3dBRkNnMzAzZzd0RWVPRHBCa3dzMUg4MXpIMnFsamU4T0VUMU9URVprd3BXejZ5cEZqblVoa1VWZ0NkYjY2REdPeWlFWUNQeFlwVU5YVGQyRjhZMk50bktWUDhLYm9WNjI0?oc=5","date":"2021-02-24","type":"pipeline","source":"Business Wire","summary":"EpiEndo Pharmaceuticals Appoints Maria Bech as New Chief Executive Officer to Support Move into Clinical Development - Business Wire","headline":"EpiEndo Pharmaceuticals Appoints Maria Bech as New Chief Executive Officer to Support Move into Clinical Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNSDNPZHZETF9QeEMzSVo1RzVzRnROVkJydVNaSkl3VzREVXhLOVgtaHdoRngxZWY3U2w0bTd4TEdjNlYwOGlYNG9RaDlwSDdmUlg3Wm5COUlzS2xSUU1NcjZ2RHk2aW9Xek1KX0czdmh1emJYV2o2RjZGaThPU0JhcklOTkUtNlhESjVz?oc=5","date":"2018-02-05","type":"regulatory","source":"Pharmafile","summary":"64% of FDC antibiotics in India are unapproved, report reveals - Pharmafile","headline":"64% of FDC antibiotics in India are unapproved, report reveals","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}